By API User
The Aboriginal Medical Services Alliance Northern Territory (AMSANT) has welcomed Donna Ah Chee as its new Chief Executive Officer. Ms Ah Chee joins AMSANT after 26 years with Central Australian Aboriginal Congress, including more than a decade as CEO, where she led one of the country’s largest Aboriginal Community Controlled Health Services (ACCHSs) through significant … Continued
By API User
Key Facts: Allergic rhinitis (commonly known as hay fever) affects around 20% of Australians Grass and weed pollens can persist from August to May Overuse of decongestant sprays can cause rebound congestion Untreated hay fever is linked to poor asthma control and sleep disturbance SYDNEY, AUSTRALIA: Hay fever is not just a spring problem, with … Continued
By API User
3 March 2026: The Digital Health Cooperative Research Centre (DHCRC), University of Sydney, TAL and Workcom have collaborated to improve the experience and recovery outcomes of Australians making income protection claims for a mental health condition. Led by researchers from the University’s Central Clinical School, the Pathways project will co-design and develop a new digital … Continued
By API User
Twenty peak patient bodies will join the Royal Australian College of GPs (RACGP) in Parliament House today to tell Australia’s leaders that patients need more affordable care and more time with their family doctors. Properly funding longer consultations is vital for patients with chronic disease, mental health concerns, and complex health needs. It also improves … Continued
By API User
Accretive Acquisition of Select Assets Includes Global Brand, UK Brewing Operations and 11 Strategic Brewpubs Expected to Generate ~$200 Million in Annual Net Revenue and ~$6 – $8 Million of Adjusted EBITDA in Fiscal 2027 Tilray’s Global Consolidated Net Revenue Expected to Reach ~$1.2 Billion on an Annualized Basis1 Conference Call Scheduled for 12:30pm ET … Continued
By API User
IRVINE, Calif.–BUSINESS WIRE– SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services to medical corporations and their clinics, today announced the appointment of Sheng-FU Hsiao as Chief Technology Officer (CTO), effective March 1, 2026. This appointment aligns with the Company’s 2026 management strategy, … Continued
By API User
Rusfertide Demonstrated Significant Improvements in Hematocrit Control, Phlebotomy Reduction and Patient Reported Outcomes for Patients with Polycythemia Vera in a Pivotal Study Submission Primarily Based on Phase 3 VERIFY Study, in Which Rusfertide Plus Standard of Care More Than Doubled Clinical Response Rates, as Well as Four-Year Efficacy and Safety Data from Phase 2 REVIVE/THRIVE … Continued
By API User
Alexion, AstraZeneca Rare Disease’s Ultomiris® (ravulizumab rch) has been listed on the Pharmaceutical Benefits Scheme (PBS) for adults with generalised myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive (Ab+). The Minister for Health and Ageing, The Hon Mark Butler MP, made the announcement at today’s World Rare Disease Day event at Parliament House. … Continued
By API User
The Centre for Medicine Use and Safety (CMUS) at the Monash Institute of Pharmaceutical Sciences (MIPS) has been successful in the bid to host the 2026 Asian Conference on Pharmacoepidemiology (ACPE). This flagship Asian event of International Society of Pharmacoepidemiology (ISPE) will be held at Monash Parkville Campus from 30 October to 1 November … Continued
By API User
March 2, 2026 – Breast Cancer Network Australia (BCNA) is highlighting the critical need for early detection of Triple Negative Breast Cancer (TNBC) ahead of Awareness Day on Tuesday March 3, warning that this fast-growing subtype of cancer is frequently missed or misdiagnosed in younger Australian women who sit outside the national screening program. With … Continued
